ema tirzepatide probes suicide risk with Novo Nordisk obesity drugs 2025 New Drug Approvals: Key

But retatrutide and cagrilintide are different from older, approved medicines in a critical way: they are investigational or not approved for general clinical use, and that status means they arent legally or safely available for routine compounding

In a 2024 review of three peptides, the FDA noted side effects like increased heart rate, chest tightening, headache, nausea, diarrhea, and elevated liver enzymes, as well as skin irritation and pain at the injection site

10.1519/JSC.0000000000003509 37

For individuals on GLP-1s, adequate dietary protein may be difficult to achieve due to reduced appetite and/or taste aversions

Todays mass use of GLP-1s has opened the door for scientists to explore other potential treatment uses for the drug, including for addiction, Alzheimers and liver, kidney and autoimmune disease

Description What kind of drug is this